secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pluri Inc. (PLUR)
CIK:        0001158780
Form:       8-K
Filed at:   2025-07-03T23:59:59+00:00
Accession:  0001213900-25-061364
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01, 5.02, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Pluri loses director Birger, triggering Nasdaq audit committee non-compliance with cure period
--------------------------------------------------------------------------------

- Doron Birger not re-elected at June 30 annual meeting; received 1,270,717 for, 2,720,350 against.
- Audit Committee now has only 2 independent directors, violating Nasdaq Rule 5605(c)(2)(A).
- Nasdaq granted cure period until earlier of next annual meeting or June 30, 2026.
- Company intends to appoint an additional independent director to regain compliance.
- Shareholders approved 2016 equity plan, advisory vote on exec comp every 2 years, and warrant exercise for Weinstein entity.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1158780/000121390025061364/0001213900-25-061364-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1158780/000121390025061364/ea0248143-8k_pluri.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-061364

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer